Baillie Gifford - INSMED INC ownership

INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 223 filers reported holding INSMED INC in Q1 2022. The put-call ratio across all filers is 0.58 and the average weighting 0.2%.

Quarter-by-quarter ownership
Baillie Gifford ownership history of INSMED INC
ValueSharesWeighting
Q1 2023$13,674
-3.2%
802
+13.4%
0.00%
Q4 2022$14,126
-5.8%
7070.0%0.00%
Q3 2022$15,000
+7.1%
7070.0%0.00%
Q2 2022$14,000
-17.6%
7070.0%0.00%
Q1 2022$17,000
-10.5%
7070.0%0.00%
Q4 2021$19,0000.0%7070.0%0.00%
Q3 2021$19,000
-13.6%
707
-10.2%
0.00%
Q2 2021$22,000
-18.5%
7870.0%0.00%
Q1 2021$27,000
+8.0%
787
+3.6%
0.00%
Q4 2020$25,0007600.00%
Other shareholders
INSMED INC shareholders Q1 2022
NameSharesValueWeighting ↓
Palo Alto Investors LP 5,889,491$148,709,64814.07%
Deep Track Capital, LP 6,000,000$151,500,0005.85%
Octagon Capital Advisors LP 1,284,000$32,421,0004.98%
SUVRETTA CAPITAL MANAGEMENT, LLC 3,446,334$87,019,9344.70%
MPM BioImpact LLC 527,458$13,318,3153.56%
Novo Holdings A/S 1,339,304$33,817,4262.50%
Bleichroeder LP 325,000$8,206,2502.02%
GREAT POINT PARTNERS LLC 394,872$9,970,5181.82%
Endurant Capital Management LP 79,471$2,006,6431.80%
SECTORAL ASSET MANAGEMENT INC 347,392$8,771,6481.71%
View complete list of INSMED INC shareholders